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We show here that copper carbenes generated from diazo 
acetamides alkylate single RNAs, mRNAs, or pools of total 
transcriptome RNA, delivering exclusively alkylation at the O
6
 
position in guanine (O
6
G). Although the reaction is effective with 
free copper some RNA fragmentation occurs, a problem we 
resolve by developing a novel water-stable copper N-heterocyclic 
carbene complex. Carboxymethyl adducts at O
6
G are known 
mutagenic lesions in DNA but their relevance in RNA biochemistry 
is unknown. As a case-in-point we re-examine an old controversy 
regarding whether O
6
G damage in RNA is susceptible to direct 
RNA repair.  
Modifications of RNA play a critical role in biology and 
biotechnology. More and more we see that post-
transcriptional RNA modification is an integral element of RNA 
regulation and gene control.1, 2 Chemists use modifications to 
improve the stability, activity, and membrane permeability of 
RNA therapeutics.3 Despite the rapid growth in research on 
RNA modifications,1 many remain difficult to synthesize. 
Although commercial phosphoramidites are available for the 
more common modifications, rarer or unnatural ones are 
typically unavailable. We have recently shown that copper-
carbenes generated from diazo compounds can alkylate the 
O6G in DNA with high chemoselectivity.4 Although divalent 
metals can degrade RNA, we wondered whether the copper-
carbene transfer to O6G would also occur in RNA and whether 
it could be used to prepare modified RNA derivatives. The 
occurrence and consequences of RNA alkylation damage is 
poorly understood,5-8 although a number of papers have 
shown that some AlkB-type iron dioxygenases can repair 
alkylation damage in RNA.9-12 We can find only four papers 
that specifically investigate O
6
G damage in RNA – all dealing 
with methylation. Two of these are recent, with one looking at 
the effects of O
6
G methylation on the fidelity of ribosomal 
translation
13
 and the other at the next generation sequencing 
(NGS) behaviour of O
6
G lesions.
14
 There are also two papers 
from the eighties with conflicting conclusions about the 
susceptibility of methylations at the O
6
G position to direct RNA 
repair.
15, 16
 Whereas these earlier repair studies used 
unselectively methylated tRNA (i.e. a mixture of lesion types), 
the technique we report here (see Fig. 1) gives us access to 
pristine O
6
G lesions in RNA, facilitating a precise reanalysis of 
whether methyl guanine methyltransferase can directly repair 
RNA. 
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Fig. 1. Top: Overview: Diazoacetamides alkylate diverse RNA substrates with a single 
type of alkylation; Bottom: The 2’hydroxyl does not interfere with O6G alkylation. 
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 Direct modification of canonical RNAs is ideal for chemical 
tailoring because RNA substrates from both chemical synthesis 
and transcription can be used directly. With current 
technology, however, it is also the most difficult approach. The 
state-of the art in this so-called post-synthetic tailoring is to 
repurpose RNA modification enzymes to accept unnatural 
substrates
17-21
 or to use DNAzymes
22
 to introduce 2’-hydroxyl 
tags. While these efforts put a strong foot forward in resolving 
the problems in RNA synthesis, more work is needed. For 
example modifications in the Watson-Crick face can still only 
be accessed by total chemical synthesis. Here we contribute 
the first example of a direct chemical reaction that is 
chemoselective for O6G RNA lesions. 
 Our previous work has shown that alkylation of DNA with 
diazo compounds is efficient and selective for O6G;4 our first 
step here was to determine whether this chemoselectivity was 
maintained in the more functionalized and less stable RNA. To 
test the impact of the 2’-hydroxyl on the copper catalysed 
reaction we prepared two diazoacetamides bearing 
biorthogonal chemical tags (Dz1 and Dz2). Reaction of these 
compounds with GMP using copper sulfate as a catalyst 
delivered clean conversion to a single modified product and 
we could confirm O
6
G selectivity by both NMR and LC-MS 
fragmentation analysis (see bottom of Fig. 1, S12-13 and 
scheme S5-7). 
 With reactivity in RNA substrates established we next 
examined whether larger RNAs were alkylated and whether 
the O
6
G selectivity was maintained. Indeed, in both a small 
oligonucleotide (see ssRNA1 in Fig. 2A), or in a whole 
transcriptome sample (see Fig. 2B) the copper catalysed 
alkylation delivered the modified product. The reaction of 
ssRNA1 is a first-in-class selective RNA modification – this type 
of direct internal RNA modification has only been achieved 
previously with enzymatic transformations or 
deoxyribozymes.19, 22-25 Although RNA degradation is observed 
(see HPLC of crude reaction in Fig. 2C, S17) the product can be 
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obtained in high purity by preparative HPLC. Derivatization 
with the strain promoted azide-alkyne cycloaddition (SPAAC) 
to attach a Cy5 fluorophore, offers further confirmation of the 
alkylation product (see Fig. 2A & C). The method outlined in 
Fig. 2 provides a simple one-step protocol to O
6
G modified 
RNAs that uses readily available materials and is easy to 
execute. 
We chose the RNA 10-mer ssRNA1 as our first substrate in 
larger RNAs to simplify product analysis. Even in the complex 
transcriptome samples, however, all alkylations were O
6
G-
type. To confirm this we first appended desthiobiotin (DTB) to 
the alkylated transcriptome samples (see Fig. 2B) through a 
copper-catalyzed azide-alkyne cycloaddition. Streptavidin 
magnetic bead selection then delivered an RNA library highly 
enriched in alkylated sequences. From here we could confirm 
the expected high selectivity for O6G alkylation through 
complete digestion,26 followed by LC-MS of the resulting 
mixture of nucleosides. The masses observed were consistent 
only with O6G alkylation products (comparison with an 
authentic standard prepared as described in Scheme S8-S9 and 
Figure S8-S9 in the ESI) and not with any of the other bases. 
 Although the copper catalysed alkylation is highly selective 
for O6G modification, the Lewis acidity and redox activity of 
copper leads to some RNA degradation with large RNAs such 
as, for example, mRNAs (see the ESI Figure S4). We therefore 
set out to identify a ligand for copper that led to a stable, yet 
active complex that did not degrade the RNA. Chelating 
nitrogen ligands were quickly ruled out because they 
completely suppressed catalysis.  A commercially available 
copper N-heterocyclic carbene (CAS#: 578743-87-0) showed 
activity, but its poor water solubility made it impractical. After 
thorough ligand screening27  of both known28-30 and new 
water-soluble NHC ligands we arrived at the electron rich NHC 
ligand 4 as one that gave a stable and catalytically active 
copper complex. The dimethylamine variant of NHC ligand 4 
was first introduced by Cesar and Lavigne for use in palladium 
catalysis,31 but its capacity to bind copper as well as its activity 
in copper catalysis has never been explored. We made an 
azide-bearing version of the Cesar-Lavigne ligand in three steps 
in 7% overall yield (see the Schemes S1-S2 in the ESI for 
complete synthetic details). The formation of the 
corresponding copper complex (1) was readily achieved via the 
silver complex in 19% yield over two steps. Crystals of 1 could 
be grown and the structure confirmed by X-ray analysis (see 
blue box in Fig. 3). Test reactions of GMP with diazoacetamide 
Dz3 confirms that 1 is active in mononucleotide alkylation (see 
Fig. 3B). Although we found the parent complex 1 was 
reasonably water-soluble, the azide tag was a precautionary 
inclusion in case we needed to include further solubilizing 
substituents. As an example, a click reaction with water 
soluble alkyne 5 cleanly delivered complex 6, which was 
completely water soluble and active in GMP alkylation (see Fig. 
3B). Nevertheless, since the precursor complex 1 was active 
and water-soluble, it was used in all further reactions. 
Importantly a degradation study with a 290 nucleotide mRNA 
prepared by in vitro transcription demonstrates that while 
copper sulfate is detrimental to RNA, the copper complex 
leads to no substantial degradation even at a 100-fold excess 
(see the ESI figure S4).  
 
Fig. 3 A An electron rich N-heterocyclic carbene ligand forms a stable complex 
with copper, which can be further derivatized. B Both the parent complex 1 and 
the derivatized complex 6 are active in guanine alkylation. 
 
 To determine whether the copper catalysed alkylation 
demonstrated any specific sequence or structural preferences 
we performed next generation sequencing (NGS) on alkylated 
transcriptome samples, using an adaptation of a protocol we 
recently developed for profiling anticancer agents.
32
 In 
contrast to our earlier protocol, here we prepared the 
sequencing libraries using RNA samples enriched in alkylation 
(prepared as described earlier in Fig. 2B, and the complete 
protocol is described in detail in the ESI).  Reverse transcription 
of the alkylated RNAs delivers cDNAs with stops and mutating 
read-throughs at sites of alkylation that we use to pinpoint 
putative sites of alkylation. With sites of alkylation identified 
we asked three questions of the sequencing data: Is there any 
sequence preference in the alkylation? Is there any structural 
preference in the alkylation? Is the guanine selectivity seen in 
the in vitro samples reflected in the NGS data? The lack of 
information in sequence logo plots showed there was no 
strong preference for alkylating any specific sequence, while 
examining significant positions across different structural types 
shows a near random distribution (i.e. the alkylation can occur 
at any G, see the ESI Figure S1-S2). Analysis of significant stops 
and mutations, however, show a strong preference for 
guanine. The fact that guanine residues dominate the 
significant mutations jibes with recent evidence that read-
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throughs in reverse transcription at sites of O
6
G alkylation are 
highly mutagenic.
14
 
 
Fig. 4 The copper catalysed RNA alkylation shows a preference for guanine 
modification as measured by both the number of significant stops (A), or the 
observed mutations (B). 
 In summary we provide a new technique for the direct 
modification of diverse RNA types. Although the method is 
effective with copper sulfate, the new Cu-NHC complex 1 leads 
to less RNA degradation, maintains alkylation activity, and has 
a chemical handle for further derivatization. More broadly 
speaking, the stability and water compatibility of 1 give it great 
potential for other types of aqueous copper catalysis. The RNA 
modification is selective for O
6
G, even in large RNAs such as 
mRNAs and in complex samples such as transcriptome isolates. 
Now that we have developed a nucleobase selective reaction 
our next goal is to use the modularity of the ligand to find 
sequence specific RNA alkylation catalysts.  
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